About
Built for the person who has to sign
PharmaTrust makes decision-support software for the people who are handed a certificate of analysis and asked to trust it.
Why it exists
A supplier's certificate arrives as a scan or a PDF. Somebody has to judge whether it is complete, whether it agrees with itself, and whether it meets the requirements for that material. Done by eye, that takes hours and the answer depends on who is reading.
In markets where re-testing capacity is limited, that reading is often the only control standing between a buyer and material they cannot verify any other way. The work deserves better tools than patience and a highlighter.
The principle
A confident wrong answer is worse than no answer.
It sounds obvious and it is expensive to honour. It means the system refuses to conclude where the evidence is thin, reports what is missing instead of guessing, and treats "the document does not say" as a finding rather than a blank. Most of the engineering here exists to make that refusal reliable.
The founder
PharmaTrust is certificate of analysis (CoA) analysis software for pharmaceutical supply chains.
PharmaTrust was founded by Dr. Qaria, a biomedical scientist with two PhDs (molecular microbiology and cancer biology) and a pharmaceutical entrepreneur whose businesses span medical supply, API sourcing and distribution across emerging markets.
The founding observation is simple and uncomfortable. Behind almost every substandard or falsified product is a certificate of analysis that somebody accepted, usually in good faith, usually without the time, tools or pharmacopoeia access to check it properly. The people carrying that risk are rarely large corporations. They are importers, distributors, hospital buyers and small manufacturers, and until now the software built for this problem was priced and designed for someone else.
If you have a certificate on your desk right now, the free tier takes ten minutes. If you have questions first, write to info@pharmatrust.tech and the founder will answer personally.
Access where the problem lives
National medicines regulators and public quality-control laboratories in World Bank-classified low-income countries can apply for free access: up to 300 automated analyses a month, no charge. The certificate-checking capacity of the world should not be concentrated where the problem is smallest.
What we do not claim
PharmaTrust supports qualified decision-making. It does not replace the responsible pharmaceutical or regulatory professional, does not certify compliance, does not act as a pharmacopoeia and does not grant regulatory approval. Automated analysis may contain errors and may not detect every problem.